23948sdkhjf
Logga in eller skapa en prenumeration för att spara artiklar
Få tillgång till allt innehåll på Life Science Sweden
Ingen bindningstid eller kortinformation krävs
Gäller endast personlig prenumeration.
Kontakta oss för en företagslösning.
Annons
Annons

Pfizer’s record year – topped the $100 billion mark

In 2022 Pfizer, as the first pharmaceutical company in history, reached an annual revenue of more than 100 billion dollars, thereby surpassing Johnson & Johnson as the industry’s top selling business.
Annons

It was primarily a huge boost from sales of products linked to the covid-19 pandemic – mainly the vaccine Comirnaty and the antiviral drug Paxlovid – that resulted in the company’s historically high revenue, reports Fierce Pharma, which has published a top 20 list of pharma companies by revenue (see below).

Annons

Johnson & Johnson had to settle for second place, followed by Roche, MSD and Abbvie, with Swedish-British Astra Zeneca coming in at ninth place.

Annons

The top 20 pharma companies by 2022 revenue (2021 revenue)

1. Pfizer $100,33 billion (81,29)

2. Johnson & Johnson $94,94 billion (93,77)

3. Roche $66,26 billion (68,71)

4. MSD (Merck & Co) $59,28 billion (48,70)

5. Abbvie $58,05 billion (56,20)

6. Novartis $50,54 billion (51,63)

7. Bristol Myers Squibb $46,16 billion (46,38)

8. Sanofi $45,22 billion (44,63)

9. AstraZeneca $44,35 billion (37,42)

10. GSK $36,15 billion (46,92)

11. Takeda Pharmaceutical Company $30,00 billion (31,57)

12. Eli Lilly $28,55 billion (28,32)

13. Gilead Sciences $27,28 billion (27,30)

14. Bayer $26,64 billion (27,94)

15. Amgen $26,32 billion (25,98)

16. Boehringer Ingelheim $25.28 billion (24,24)

17. Novo Nordisk $25,00 billion (22,38)

18. Moderna $19,26 billion (18,47)

19. Merck KGaA $19,16 billion (19,11)

20. Biontech 18,20 billion (22,43)

Source: Fierce Pharma

Annons
Annons
Annons
News in English Se tema
Annons Annons
BREAKING
{{ article.headline }}
0.047|instance-web01